SCTR
South Carolina Clinical & Translational Research
Manager of Research Operations
Julia Brenner
You are dying to bring something to the holiday party!
Linda!
The PRG has 43 studies
False we currently have 54 active studies
This form is required by federal regulations for Investigators to disclose certain financial interests to ensure that the design, conduct or reporting of federally-funded projects will not be biased.
Financial Disclosure
OCR and ORSP
Office of Clinical Research
Office of Research and Sponsored Programs
Director of Research Administration
Erica Blender Brown
If you have an issue with your computer, a software program, or
Originality, Attributability, Legibility, Completeness, Availability, and Accuracy are parts of ALCOA+
True! Please continue to do these things :-)
This handbook details a study’s conduct and operations describing a study’s organization, operational data definitions, recruitment, screening, enrollment, randomization, follow-up procedures, data collection methods, data flow, case report forms (CRFs), and quality control procedures.
Manual of Operations (MOO)
CTA
Clinical Trial Agreement
Vice Chair of Clinical Research, The Charles P. Darby Department of Pediatrics
John M. Costello, MD
If you receive an invoice from EPIC research, or if you foresee a charge related to a study?
Jasmen Allen and peds-grants@musc.edu
Clinical Trial Phase 2 is done to determine the safety of an IND.
False! Safety of trials are determined during Phase 1. Phase 2 continues with safety but is to determine safe dosing.
Signing this document provides assurance that a trial will be conducted according to all stipulations of the protocol and to local legal and regulatory requirements and applicable US federal regulations and ICH E6 Good Clinical Practice (GCP) guidelines.
Protocol Signature Page
ROC
Research Operations and Collaborations
Chair, The Dr. Charles P. Darby, Jr. Department of Pediatrics
Andrew M. Atz, MD
If something is broken (door handle, faucet, toilet)....
Linda
A drug is submitted for FDA approval following Phase IV of a clinical trial.
False
A drug is submitted for FDA approval following Phase III (safety and efficacy) and prior to Phase IV (post approval surveillance)
An agreement between the investigator and the FDA Code of Federal Regulations, when running a trial to study a new drug or agent, that verifies the investigator has the experience and background required to conduct the trial in a way that is ethical and scientifically sound.
1572
IATA
International Air Transport Association
Associate Director Research Opportunities and Collaborations
Signe Denmark, MS, CCRP
A general question concerning clincard
clincard@musc.edu
True!
This is a letter usually obtained by the by the sponsor from the FDA verifying that the IND was submitted and verified by the FDA to be used for research. (It will usually tell if an IND number is required)
IND Letter